Skip to main content
Top
Published in: Breast Cancer Research and Treatment 3/2016

01-04-2016 | Clinical trial

Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population

Authors: Seung Taek Lim, Jung Eun Choi, Sei Joong Kim, Hyun Ah Kim, Ji Young Kim, Heung Kyu Park, Young Jin Suh

Published in: Breast Cancer Research and Treatment | Issue 3/2016

Login to get access

Abstract

Previous studies have not considered the axillary lymph node status when investigating the prognostic role of tumor location according to each molecular subtype. The present study aimed to investigate the prognostic implication of tumor location according to each molecular subtype in Korean invasive ductal carcinoma (IDC) patients with axillary lymph node metastasis. Data from 7856 Korean IDC women with axillary lymph node metastasis were retrospectively analyzed. According to tumor location, patients were divided into the following groups: upper-outer quadrant, lower-outer quadrant, upper-inner quadrant, lower-inner quadrant (LIQ), and central group. Overall survival (OS) and breast cancer-specific survival (BCSS) were evaluated according to tumor location and molecular subtype. A subgroup analysis based on tumor size categorization was also performed. The patients’ mean age was 47.97 ± 9.64 years, and the median follow-up time was 90 months. The LIQ group showed significantly worse prognosis in OS and BCSS (76.4 and 83.3 %, respectively) compared with the other groups, which was only significant in human epidermal growth factor receptor 2 (HER2) overexpression and triple-negative (TN) subtypes. In the subgroup analysis according to tumor size, the LIQ group showed a significantly worse prognosis in OS and BCSS compared with the other groups, in HER2 and TN subtypes, and only in patients with more than T2 stage. In Korean IDC patients with axillary lymph node metastasis, LIQ tumor location was associated with poor prognosis among those with HER2 and TN molecular subtypes and especially in those with more than T2 stage.
Literature
1.
go back to reference Toikkanen S, Pylkkänen L, Joensuu H (1967) Invasive lobular carcinoma of the breast had better short- and long- survival than invasive ductal carcinoma. Br J Cancer 76:1234–1240CrossRef Toikkanen S, Pylkkänen L, Joensuu H (1967) Invasive lobular carcinoma of the breast had better short- and long- survival than invasive ductal carcinoma. Br J Cancer 76:1234–1240CrossRef
2.
go back to reference Nemoto T, Vana J, Bedwani RN et al (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45:2917–2924CrossRefPubMed Nemoto T, Vana J, Bedwani RN et al (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45:2917–2924CrossRefPubMed
3.
go back to reference Biglia N, Maggiorotto F, Liberale V et al (2013) Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Eur J Sur Oncol 39:455–460CrossRef Biglia N, Maggiorotto F, Liberale V et al (2013) Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Eur J Sur Oncol 39:455–460CrossRef
4.
go back to reference Garne JP, Aspegren K, Linell F et al (1994) Primary prognostic factors in invasive breast cancer with special reference to ductal carcinoma and histologic malignancy grade. Cancer 73:1438–1448CrossRefPubMed Garne JP, Aspegren K, Linell F et al (1994) Primary prognostic factors in invasive breast cancer with special reference to ductal carcinoma and histologic malignancy grade. Cancer 73:1438–1448CrossRefPubMed
5.
go back to reference Sarp S, Fioretta G, Verkooijen HM et al (2007) Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer. Ann Surg Oncol 14:1031–1039CrossRefPubMed Sarp S, Fioretta G, Verkooijen HM et al (2007) Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer. Ann Surg Oncol 14:1031–1039CrossRefPubMed
6.
go back to reference Wu S, Zhou J, Ren Y et al (2014) Tumor location is a prognostic factor for survival of Chinese women with T1-2N0M0 breast cancer. Int J Surg 12:394–398CrossRefPubMed Wu S, Zhou J, Ren Y et al (2014) Tumor location is a prognostic factor for survival of Chinese women with T1-2N0M0 breast cancer. Int J Surg 12:394–398CrossRefPubMed
7.
go back to reference Lohrisch C, Jackdon J, Jones A et al (2000) Relationship between tumor location and relapse in 6781 women with early invasive breast cancer. J Clin Oncol 18:2828–2835PubMed Lohrisch C, Jackdon J, Jones A et al (2000) Relationship between tumor location and relapse in 6781 women with early invasive breast cancer. J Clin Oncol 18:2828–2835PubMed
8.
go back to reference Colleoni M, Zahrieh D, Gelber RD et al (2005) Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol 23:1390–1400CrossRefPubMed Colleoni M, Zahrieh D, Gelber RD et al (2005) Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol 23:1390–1400CrossRefPubMed
9.
go back to reference Montagna E, Bagnardi V, Rotmensz N et al (2015) Outcome and medial presentation of breast cancer: European Institute Of Oncology Experience. Clin Breast Cancer 15:440–447CrossRefPubMed Montagna E, Bagnardi V, Rotmensz N et al (2015) Outcome and medial presentation of breast cancer: European Institute Of Oncology Experience. Clin Breast Cancer 15:440–447CrossRefPubMed
10.
go back to reference Yu J, Li G, Li J et al (2005) The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys 61:874–878CrossRefPubMed Yu J, Li G, Li J et al (2005) The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys 61:874–878CrossRefPubMed
11.
go back to reference Klauber-DeMore N, Bevilacqua JL, Van Zee KJ et al (2001) Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg 193:547–555CrossRefPubMed Klauber-DeMore N, Bevilacqua JL, Van Zee KJ et al (2001) Comprehensive review of the management of internal mammary lymph node metastases in breast cancer. J Am Coll Surg 193:547–555CrossRefPubMed
12.
go back to reference Veronesi U, Cascinelli N, Bufalino R et al (1983) Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198:681–684CrossRefPubMedPubMedCentral Veronesi U, Cascinelli N, Bufalino R et al (1983) Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg 198:681–684CrossRefPubMedPubMedCentral
13.
go back to reference Yao MS, Kurland BF, Smith AH et al (2007) Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol 14:2985–2993CrossRefPubMed Yao MS, Kurland BF, Smith AH et al (2007) Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer. Ann Surg Oncol 14:2985–2993CrossRefPubMed
14.
go back to reference Moon HG, Han W, Noh DY (2009) Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society. J Clin Oncol 27:5899–5905CrossRefPubMed Moon HG, Han W, Noh DY (2009) Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society. J Clin Oncol 27:5899–5905CrossRefPubMed
16.
go back to reference González-soto MJ, Bajén MT, Pla MJ et al (2006) Influence of tumor location in patients with breast cancer on the sentinel node detection. Rev Esp Med Nucl 25:98–102CrossRefPubMed González-soto MJ, Bajén MT, Pla MJ et al (2006) Influence of tumor location in patients with breast cancer on the sentinel node detection. Rev Esp Med Nucl 25:98–102CrossRefPubMed
17.
go back to reference Munñoz M, Fernández-Aceñero MJ, Martín S et al (2009) Prognostic significance of molecular classification of breast invasive ductal carcinoma. Arch Gynecol Obstet 280:43–48CrossRef Munñoz M, Fernández-Aceñero MJ, Martín S et al (2009) Prognostic significance of molecular classification of breast invasive ductal carcinoma. Arch Gynecol Obstet 280:43–48CrossRef
18.
go back to reference Huang O, Wang L, Shen K et al (2008) Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 107:379–387CrossRefPubMed Huang O, Wang L, Shen K et al (2008) Breast cancer subpopulation with high risk of internal mammary lymph nodes metastasis: analysis of 2269 Chinese breast cancer patients treated with extended radical mastectomy. Breast Cancer Res Treat 107:379–387CrossRefPubMed
19.
go back to reference Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials. Lancet 366:2087–2106CrossRefPubMed Clarke M, Collins R, Darby S et al (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15 year survival: an overview of the randomized trials. Lancet 366:2087–2106CrossRefPubMed
20.
go back to reference Poortmans PM, Collette S, Kirkove C et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373:317–327CrossRefPubMed Poortmans PM, Collette S, Kirkove C et al (2015) Internal mammary and medial supraclavicular irradiation in breast cancer. N Engl J Med 373:317–327CrossRefPubMed
21.
go back to reference Allott EH, Cohen SM, Geradts J et al (2016) Performance of three-biomarker immunohistochemistry for intrinsic breast cancer subtyping in the AMBER consortium. Cancer Epidemiol Biomark Prev 25:470–478CrossRef Allott EH, Cohen SM, Geradts J et al (2016) Performance of three-biomarker immunohistochemistry for intrinsic breast cancer subtyping in the AMBER consortium. Cancer Epidemiol Biomark Prev 25:470–478CrossRef
Metadata
Title
Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population
Authors
Seung Taek Lim
Jung Eun Choi
Sei Joong Kim
Hyun Ah Kim
Ji Young Kim
Heung Kyu Park
Young Jin Suh
Publication date
01-04-2016
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 3/2016
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-016-3771-6

Other articles of this Issue 3/2016

Breast Cancer Research and Treatment 3/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine